These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37328581)

  • 1. Association of ACE gene polymorphisms with in-stent restenosis by stent type (biomime, supraflex, xience).
    Klashami ZN; Roudbordeh MG; Asadi M; Ebrahimi P; Amoli MM
    Mol Biol Rep; 2023 Aug; 50(8):6445-6455. PubMed ID: 37328581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of the rs1799752 polymorphism of the angiotensin-converting enzyme gene and the rs699 polymorphism of the angiotensinogen gene to the process of in-stent restenosis in a population of Polish patients with stable coronary artery disease.
    Osadnik T; Strzelczyk JK; Fronczek M; Bujak K; Reguła R; Gonera M; Gawlita M; Kurek A; Wasilewski J; Lekston A; Gierlotka M; Hawranek M; Ostrowska Z; Wiczkowski A; Poloński L; Gąsior M
    Adv Med Sci; 2016 Sep; 61(2):276-281. PubMed ID: 27162064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between angiotensin converting enzyme gene polymorphism, coronary artery disease, and stent restenosis: the role of angiotensin converting enzyme inhibitors in stent restenosis in patients with diabetes mellitus.
    Guneri S; Baris N; Aytekin D; Akdeniz B; Pekel N; Bozdemir V
    Int Heart J; 2005 Sep; 46(5):889-97. PubMed ID: 16272779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of the I/D polymorphism and plasma angiotensin-converting enzyme (ACE) as risk factors for stent restenosis.
    Ribichini F; Ferrero V; Matullo G; Feola M; Vado A; Camilla T; Guarrera S; Carturan S; Vassanelli C; Uslenghi E; Piazza A
    Clin Sci (Lond); 2004 Oct; 107(4):381-9. PubMed ID: 15101817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation.
    Ferrari M; Mudra H; Grip L; Voudris V; Schächinger V; de Jaegere P; Rieber J; Hausmann D; Rothman M; Koschyk DH; Figulla HR;
    Cardiology; 2002; 97(1):29-36. PubMed ID: 11893827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J; Liu Y; Cui RZ; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM
    Chin Med J (Engl); 2013 Mar; 126(6):1019-25. PubMed ID: 23506572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of
    Zhang M; Wang J; Zhang Y; Zhang P; Jia Z; Ren M; Jia X; Ma L; Gao M; Hou Y
    Drug Des Devel Ther; 2020; 14():669-676. PubMed ID: 32109992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin-aldosterone system (RAAS) gene polymorphism as a risk factor of coronary in-stent restenosis.
    Ryu SK; Cho EY; Park HY; Im EK; Jang YS; Shin GJ; Shim WH; Cho SY
    Yonsei Med J; 2002 Aug; 43(4):461-72. PubMed ID: 12205735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
    Zeng WP; Zhang R; Li R; Luo JF; Hu XF
    PLoS One; 2017; 12(1):e0170964. PubMed ID: 28129392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of ACE insertion or deletion polymorphisms with the risk of coronary restenosis after percutaneous coronary intervention: A meta-analysis.
    Miao HW; Gong H
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):844-50. PubMed ID: 26195267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement.
    Koch W; Kastrati A; Mehilli J; Böttiger C; von Beckerath N; Schömig A
    Circulation; 2000 Jul; 102(2):197-202. PubMed ID: 10889131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.
    Koch W; Mehilli J; von Beckerath N; Böttiger C; Schömig A; Kastrati A
    J Am Coll Cardiol; 2003 Jun; 41(11):1957-61. PubMed ID: 12798565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between angiotensin-1 converting enzyme gene polymorphism and in-stent restenosis].
    Qu X; Zhao J; Liu P; Song L; Zhao K; Liu H; Huang Y
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):474-6. PubMed ID: 12133519
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Osama S; Wirth F; Zahra G; Barbara C; Xuereb RG; Camilleri L; Azzopardi LM
    Drug Metab Pers Ther; 2021 Jan; 37(2):155-161. PubMed ID: 34851561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association found between the insertion/deletion of a 287-bp alu repeat sequence within intron 16 of the angiotensin-I-converting enzyme (ACE) gene in Mexican patients and binary restenosis after coronary stenting.
    Martínez-Ríos MA; Peña-Duque MA; Fragoso JM; Delgadillo-Rodríguez H; Pérez-Hernández N; Miranda-Malpica E; Rodríguez-Pérez JM; González-Quesada C; Vargas-Alarcón G
    Clin Chim Acta; 2008 Nov; 397(1-2):65-7. PubMed ID: 18706898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinapril prevents restenosis after coronary stenting in patients with angiotensin-converting enzyme D allele.
    Okumura K; Sone T; Kondo J; Tsuboi H; Mukawa H; Tsuzuki M; Imai H; Kamiya H; Mabuchi Y; Matsui H; Hayakawa T
    Circ J; 2002 Apr; 66(4):311-6. PubMed ID: 11954942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1.
    Wijpkema JS; van Haelst PL; Monraats PS; Bruinenberg M; Zwinderman AH; Zijlstra F; van der Steege G; de Winter RJ; Doevendans PA; Waltenberger J; Jukema JW; Tio RA
    Pharmacogenet Genomics; 2006 May; 16(5):331-7. PubMed ID: 16609364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotypes of the angiotensin-converting enzyme (ACE) gene are associated with coronary artery disease but not with restenosis after coronary stenting.
    Martínez-Ríos MA; Alvarez-León E; Totomoch A; Angeles J; Peña-Duque MA; Delgadillo-Rodríguez H; Martínez-Rodríguez N; Ramírez-Fuentes S; Fragoso JM; Vargas-Alarcón G
    Exp Mol Pathol; 2014 Aug; 97(1):166-70. PubMed ID: 24995885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.